Irving, Texas-based McKesson Corporation (MCK) distributes pharmaceuticals, medical-surgical supplies, and health and beauty care products. With a market cap of $118.4 billion, the company also develops, implements, and supports software that facilitates the integration of data throughout the health enterprise. In addition, McKesson offers analytic, care management, and patient solutions for payers. The healthcare giant is expected to announce its fiscal second-quarter earnings for 2027 after the market closes on Wednesday, Nov. 4.
Ahead of the event, analysts expect McKesson to report a profit of $10.69 per share on a diluted basis, up 8.4% from $9.86 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.